Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer

Nan Dai; Xiao-Jing Cao; Meng-Xia Li; Yi Qing; Ling Liao; Xian-Feng Lu; Shi-Heng Zhang; Zheng Li; Yu-Xin Yang; Dong Wang

doi:10.1371/journal.pone.0058001

Loading metrics

Open Access

Peer-reviewed

Research Article

Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer

Nan Dai ,

Contributed equally to this work with: Nan Dai, Xiao-Jing Cao

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Xiao-Jing Cao ,

Contributed equally to this work with: Nan Dai, Xiao-Jing Cao

Affiliation Department of Pathology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China
⨯
Meng-Xia Li,

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Yi Qing,

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Ling Liao,

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Xian-Feng Lu,

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Shi-Heng Zhang,

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Zheng Li,

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Yu-Xin Yang,

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯
Dong Wang

* E-mail: dongwang64@hotmail.com

Affiliation Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
⨯

Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer

Nan Dai,
Xiao-Jing Cao,
Meng-Xia Li,
Yi Qing,
Ling Liao,
Xian-Feng Lu,
Shi-Heng Zhang,
Zheng Li,
Yu-Xin Yang,
Dong Wang

Published: March 5, 2013
https://doi.org/10.1371/journal.pone.0058001

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Autoantibodies
Is the Subject Area "Autoantibodies" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.